Merck Makes Deal to Develop Schizophrenia Drug
15688
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
416215
Swiss biotech company Addex  Pharmaceuticals SA  could receive more than $700  million from Merck & Co Inc  for a licensing deal on its  ADX63365 drug for schizophrenia, it said on Thursday.
265877
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal to buy Swiss biotech firm Serono on Thursday,   creating a new force in European pharmaceuticals.
96120
An experimental treatment for schizophrenia produced fewer worrisome side effects compared with drugs currently in use, its makers said on Wednesday.
640611
Cambridge cancer drug maker Ariad Pharmaceuticals Inc. signed a major deal with Merck &amp; Co. Inc. yesterday in which the global pharmaceutical giant will pay $75 million to collaborate on developing and selling Ariad's experimental drug to treat sarcomas, a type of tumor that attacks fat, muscle, and bone.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
110719
German drugmaker Merck MRCG.DE on   Thursday agreed to buy a 64.5 percent stake in rival Serono   SEO.VX in a surprise deal valued over 10 billion Swiss francs   ($8.3 billion), creating a new force in European   pharmaceuticals.
733936
The first new class of drugs in more than a decade for treating schizophrenia worked at least as well in a clinical trial as standard medications, but with fewer side-effects, a new study showed.
130777
The first new class of drugs in more than a decade for treating schizophrenia worked at least as well in a clinical trial as standard medications, a study released Sunday showed.
57638
Drug maker Merck & Co.  said on Wednesday it agreed to settle tax disputes with the U.S. Internal Revenue Service at a net cash cost of about $2.3 billion.
150005
Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
63904
A new study finds that an older antipsychotic drug is cheaper and equally effective for some patients with schizophrenia, sending makers of newer drugs scrambling to defend their products on Friday.
331733
Researchers said on Monday they have pinpointed the reason some drugs used to treat mental illnesses like schizophrenia cause patients to gain a lot of weight, raising hope for developing drugs without this side effect.
214430
With its stock plunging, drug giant Merck has adopted a plan that could give top executives big bonuses if the company is taken over.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
567241
Drug company Eli Lilly  has  encouraged primary care physicians to use Zyprexa, a powerful  drug for schizophrenia and bipolar disorder, in patients who  did not have either condition, the New York Times reported on  its Web site on Monday, citing internal Lilly marketing  materials.